Biological activities of a new acetalic ether of oestradiol: 17 -(1',4'-dioxan-2'-yloxy)-oestra-1,3,5(10)-trien-3-ol (17-dioxanyloestradiol).

G. Agresta,C. Gandolfi,F. Guidobono,V. Mandelli,L. Montesanti,A. Pecile
DOI: https://doi.org/10.1530/ACTA.0.0690095
Acta Endocrinologica
Abstract:The estrogenic and antifertility activity of a new acetalic ether of estradiol (17-dioxanylestradiol) with a formula of 17beta-(14-dioxan-2-yloxy)-estra-13 5(10)-trien-3-ol (DE) was evaluated in the rat and mouse by various biological tests using ethinyl estradiol (EE) as a reference standard. Orally administered DE gave an uterotrophic response considerably lower than that of EE for a DE/EE ratio of .170 in the rat and .0195 in the mouse. The decreased estrogenic activity of DE was confirmed by the vaginal cornification test (ED50 .32 for EE and 9.4 for DE) and the dehydrogenase activity test of the vaginal epithelium in the mouse (DE/EE potency ratio of .014). 10 mcg/day of DE had a complete antifertility effect in rats while 30 mcg/day of EE had a doubtful antifertility effect. In testing gonadotropin inhibiting activity the DE/EE ratio was .500 in parabiotic couples .695 in the inhibition of testicular weight increase in immature rats and 2.1007 in the inhibition of compensatory ovarian hypertrophy. The results further confirm that there is a dissociation of estrogenic activity and gonadotropin inhibiting potency with DE and suggest that the antifertility effect may be due to alterations other than gonadotropin-blockade.
What problem does this paper attempt to address?